Regulatory & Legal

Operational failures at a key Texas plant and a sudden drop in chlorine demand force chemical giant Olin Corp. to drastically cut its Q4 earnings forecast.

The first system pairing a one-year implantable glucose monitor with an automated insulin pump is now available, promising to transform daily life for people with diabetes.

With 155 illnesses and hundreds of products recalled, a widespread Salmonella outbreak linked to pistachios has put Canada's food safety system to the test.

The 2025-2030 Dietary Guidelines praise eggs as a top protein, but experts question the new, broader focus on animal products and increased protein intake.

A historic $1 million estate gift launches Pink Fund's 20th anniversary, securing its future and highlighting the hidden financial burdens of breast cancer.

The American Library Association marks its sesquicentennial with a year of celebration, highlighting its legacy and confronting a modern surge in censorship.

MiNK Therapeutics and UW–Madison launch a trial for an 'off-the-shelf' cell therapy, aiming to prevent deadly Graft-Versus-Host Disease (GvHD).

The SEC proposes a landmark update to its 'small entity' definition, a move poised to slash red tape for thousands of firms and foster market competition.

The diversified company is pivoting to Web3, partnering to transform high-value memorabilia like sports cards and art into tradable digital assets.

As regulators circle the PBM industry, LucyRx appoints veteran Christin Bassett as CLO to steer its growth and reinforce its commitment to transparency.

ZenaTech's rapid acquisitions signal a land grab in the booming Drone as a Service market, but can its high-risk, high-reward strategy pay off?

A new platform gives celebrities real-time, licensed access to their own event photos, aiming to solve a major legal and branding headache for the industry.

As stronger, cheaper vapes fuel a youth addiction crisis, a new initiative reframes relapse and offers digital tools to help Gen Z finally break free.

The dessert franchise touts record sales and coast-to-coast expansion, signaling a froyo comeback. But a closer look reveals a complex story of high hopes and financial risks.

The AI-powered marketplace adds advanced materials, CMMC compliance, and new manufacturing controls to meet demands from critical, regulated industries.

With a new EV plant in Santa Teresa, GreenPower aims for market dominance while New Mexico pushes its ambitious clean energy and economic development goals.

Frontier Airlines appoints decade-long veteran James Dempsey as its new CEO and raises its Q4 earnings outlook, signaling operational resilience.

With multiple clinical trials advancing and a savvy global expansion, RESTEM is poised to challenge the treatment paradigm for autoimmune disorders.

With a major cash infusion and key pipeline milestones, Xilio Therapeutics validates its tumor-activated approach to fighting cancer and extends its runway to 2027.

Positive early human safety data for its lead drug and new candidates for Rett syndrome and MASH signal a pivotal year for ProQR's Axiomer technology.